HIV Citation List: April 1 - April 15, 2010
Pubmed citations:
1. Amino Acid Derivatives, Part 4: Synthesis and Anti-HIV Activity of New Naphthalene Derivatives. Hamad NS, Al-Haidery NH, Al-Masoudi IA, Sabri M, Sabri L, Al-Masoudi NA. Arch Pharm (Weinheim). 2010 Apr 8. [Epub ahead of print]PMID: 20379971
2. First isolation and characterization of a novel lectin with potent antitumor activity from a Russula mushroom. Zhang G, Sun J, Wang H, Ng TB. Phytomedicine. 2010 Apr 6. [Epub ahead of print]PMID: 20378319
3. "Viologen" Dendrimers as Antiviral Agents: The Effect of Charge Number and Distance (dagger). Asaftei S, De Clercq E. J Med Chem. 2010 Apr 8. [Epub ahead of print]PMID: 20377249
4. Small molecular inhibitors for HIV-1 replication through specifically stabilizing APOBEC3G. Cen S, Peng ZG, Li XY, Li ZR, Ma J, Wang YM, Fan B, You XF, Wang YP, Liu F, Shao RG, Zhao LX, Yu L, Jiang JD. J Biol Chem. 2010 Apr 2. [Epub ahead of print]PMID: 20363737
5. Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV. Feng XQ, Zeng ZS, Liang YH, Chen FE, Pannecouque C, Balzarini J, De Clercq E. Bioorg Med Chem. 2010 Apr 1;18(7):2370-4. Epub 2010 Mar 9.PMID: 20307984
6. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents. Miller JF, Turner EM, Gudmundsson KS, Jenkinson S, Spaltenstein A, Thomson M, Wheelan P. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2125-8. Epub 2010 Feb 14.PMID: 20207537
7. Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1. Catalano JG, Gudmundsson KS, Svolto A, Boggs SD, Miller JF, Spaltenstein A, Thomson M, Wheelan P, Minick DJ, Phelps DP, Jenkinson S. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2186-90. Epub 2010 Feb 12.PMID: 20194023
8. Binding of multivalent anionic porphyrins to V3 loop fragments of an HIV-1 envelope and their antiviral activity. Watanabe K, Negi S, Sugiura Y, Kiriyama A, Honbo A, Iga K, Kodama EN, Naitoh T, Matsuoka M, Kano K. Chem Asian J. 2010 Apr 1;5(4):825-34.PMID: 20112333
9. Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef. Ptak RG, Gentry BG, Hartman TL, Watson KM, Osterling MC, Buckheit RW Jr, Townsend LB, Drach JC. Antimicrob Agents Chemother. 2010 Apr;54(4):1512-9. Epub 2010 Jan 19.PMID: 20086149
ISI Web of Knowledge citations:
10. Copper-catalyzed Synthesis and Antimicrobial Activity of Disubstituted 1,2,3-Triazoles Starting from 1-Propargyluracils and Ethyl (4-Azido-1,2,3-trihydroxybutyl)furan-3-carboxylate. El-Sayed, WA; Abdel-Rahman, AAH. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 2010; 65(1): 57-66.
11. Synthesis and Evaluation of in Vitro Biological Activity of 4-Substituted Arylpiperazine Derivatives of 1,7,8,9-Tetrachloro-10,10-dimethoxy-4-azatricyclo[5.2.1.0(2,6)]dec-8-ene -3,5-dione. Kossakowski, J; Pakosinska-Parys, M; Struga, M; Dybala, I; Koziol, AE; La Colla, P; Marongiu, LE; Ibba, C; Collu, D; Loddo, R. MOLECULES, 2009; 14(12): 5189-5202.
12. Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4] arene scaffold. Tsou, LK; Dutschman, GE; Gullen, EA; Telpoukhovskaia, M; Cheng, YC; Hamilton, AD. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(7): 2137-2139.
13. Bioisostere of valtrate, anti-HIV principle by inhibition for nuclear export of Rev. Tamura, S; Shimizu, N; Fujiwara, K; Kaneko, M; Kimura, T; Murakami, N. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(7): 2159-2162.
14. Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1. Catalano, JG; Gudmundsson, KS; Svolto, A; Boggs, SD; Miller, JF; Spaltenstein, A; Thomson, M; Wheelan, P; Minick, DJ; Phelps, DP; Jenkinson, S. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(7): 2186-2190.
15. Discovery of novel (S)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach. Zhang, HS; Feng, DZ; Chen, L; Long, YQ. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010; 20(7): 2219-2223.
16. Inhibition of HIV-1 Replication by a Bis-Thiadiazolbenzene-1,2-Diamine That Chelates Zinc Ions from Retroviral Nucleocapsid Zinc Fingers. Pannecouque, C; Szafarowicz, B; Volkova, N; Bakulev, V; Dehaen, W; Mely, Y; Daelemans, D. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010; 54(4): 1461-1468.
17. Design, Synthesis and Anti-HIV Integrase Evaluation of N-(5-Chloro-8-Hydroxy-2-Styrylquinolin-7-yl)Benzenesulfonamide Derivatives. Jiao, ZG; He, HQ; Zeng, CC; Tan, JJ; Hu, LM; Wang, CX. MOLECULES, 2010; 15(3): 1903-1917.
18. Novel Thiazolidinone Derivatives with an Uncommon Mechanism of Inhibition Towards HIV-1 Reverse Transcriptase. Pitta, E; Crespan, E; Geronikaki, A; Maga, G; Samuele, A. LETTERS IN DRUG DESIGN & DISCOVERY, 2010; 7(4): 228-234.
19. Inhibition of HIV-1 Replication by Isoxazolidine and Isoxazole Sulfonamides. Loh, B; Vozzolo, L; Mok, BJ; Lee, CC; Fitzmaurice, RJ; Caddick, S; Fassati, A. CHEMICAL BIOLOGY & DRUG DESIGN, 2010; 75(5): 461-474.